EUVIMEDEUVIMED entdecken
Crossref

Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver

Haiying Ran, Wei Sun, Liting Wang, Xiaoyang Wang, Haili Yu, Jiajia Chen, Fang Liu, Zhiyin Chao, Qi Pu, Yang Liu, Youlong Zeng, Zhangfu Li und 2 weitere

PROTEOMICS · 2023

DOI: 10.1002/pmic.202300043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, 2023. Verfasst von Haiying Ran und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Analysis Center, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Peroxisome Proliferator-Activated Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid droplets (LDs) are multifunctional organelles consisting of a central compartment of non‐polar lipids shielded from the cytoplasm by a phospholipid monolayer. The excessive accumulation of LDs in cells is closely related to the development and progression of many diseases in humans and animals, such as liver‐related and cardiovascular diseases. Thus, regulating the LDs size and abundance is necessary to maintain metabolic homeostasis. This study found that lipopolysaccharide (LPS) stimulation reduced the LDs content in the mouse liver. We tried to explain the possible molecular mechanisms at the broad protein and mRNA levels, finding that inhibition of the peroxisome proliferator‐activated receptors (PPAR) signalling pathway by LPS may be a critical factor in reducing LDs content.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesPeroxisome Proliferator-Activated ReceptorsHumansAnimalsMiceLipid DropletsTranscriptomeProteomicsLiverLipid Metabolism

Stichwörter der Autor:innen

RNA sequencinglipid dropletlipopolysaccharideperoxisome proliferator-activated receptors signalling pathwayquantitative proteomics

Substanzen

LipopolysaccharidesPeroxisome Proliferator-Activated Receptors

Autor:innen und Institutionen

  • Biomedical Analysis Center, Army Medical University, Chongqing, China.
  • Hepato-Pancreato-Biliary Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong Province, China.

ORCID-Profile: Jiangbei Yuan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Ran, H., Sun, W., Wang, L., Wang, X., Yu, H., Chen, J., Liu, F., Chao, Z., Pu, Q., Liu, Y., Zeng, Y., Li, Z., Wan, Y., & Yuan, J. (2023). Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver. PROTEOMICS. https://doi.org/10.1002/pmic.202300043

Vancouver

Ran H, Sun W, Wang L, Wang X, Yu H, Chen J, et al. Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver. PROTEOMICS. 2023. doi:10.1002/pmic.202300043

BibTeX
@article{Ran2023,
  author = {Ran, Haiying and Sun, Wei and Wang, Liting and Wang, Xiaoyang and Yu, Haili and Chen, Jiajia and Liu, Fang and Chao, Zhiyin and Pu, Qi and Liu, Yang and Zeng, Youlong and Li, Zhangfu and Wan, Ying and Yuan, Jiangbei},
  title = {Proteomics coupled transcriptomics reveals lipopolysaccharide inhibiting peroxisome proliferator‐activated receptors signalling pathway to reduce lipid droplets accumulation in mouse liver},
  journal = {PROTEOMICS},
  year = {2023},
  doi = {10.1002/pmic.202300043}
}
Kostenlos starten →